ArticleHepatitis monthly2016

A Cost-Utility and Cost-Effectiveness Analysis of Different Oral Antiviral Medications in Patients With HBeAg-Negative Chronic Hepatitis B in Iran: An Economic Microsimulation Decision Model.

Khosro Keshavarz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.